Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 161

Similar articles for PubMed (Select 23258502)

1.

Pulmonary hypertension complicated by pericardial effusion: a single center experience.

Honeycutt GR, Safdar Z.

Ther Adv Respir Dis. 2013 Jun;7(3):151-9. doi: 10.1177/1753465812471416. Epub 2012 Dec 20.

2.

Pericardial effusions in pulmonary arterial hypertension: characteristics, prognosis, and role of drainage.

Fenstad ER, Le RJ, Sinak LJ, Maradit-Kremers H, Ammash NM, Ayalew AM, Villarraga HR, Oh JK, Frantz RP, McCully RB, McGoon MD, Kane GC.

Chest. 2013 Nov;144(5):1530-8. doi: 10.1378/chest.12-3033.

PMID:
23949692
3.

Poor outcomes associated with drainage of pericardial effusions in patients with pulmonary arterial hypertension.

Hemnes AR, Gaine SP, Wiener CM.

South Med J. 2008 May;101(5):490-4. doi: 10.1097/SMJ.0b013e31816c0169.

PMID:
18414173
4.

Incidence and significance of pericardial effusion in patients with pulmonary arterial hypertension.

Shimony A, Fox BD, Langleben D, Rudski LG.

Can J Cardiol. 2013 Jun;29(6):678-82. doi: 10.1016/j.cjca.2012.04.009. Epub 2012 Jun 19.

PMID:
22717247
5.

[Chronic intractable pericardial effusion associated with pulmonary hypertension: report of two cases].

Iwasaki K, Kusachi S, Nishiyama O, Ueda M, Kita T, Haraoka S.

Kokyu To Junkan. 1990 Jul;38(7):709-12. Japanese.

PMID:
2402575
6.

Risk factors affecting the survival rate in patients with symptomatic pericardial effusion undergoing surgical intervention.

Mirhosseini SM, Fakhri M, Mozaffary A, Lotfaliany M, Behzadnia N, Ansari Aval Z, Ghiasi SM, Boloursaz MR, Masjedi MR.

Interact Cardiovasc Thorac Surg. 2013 Apr;16(4):495-500. doi: 10.1093/icvts/ivs491. Epub 2012 Dec 18.

7.

Pericardial effusion after cardiac surgery: risk factors, patient profiles, and contemporary management.

Ashikhmina EA, Schaff HV, Sinak LJ, Li Z, Dearani JA, Suri RM, Park SJ, Orszulak TA, Sundt TM 3rd.

Ann Thorac Surg. 2010 Jan;89(1):112-8. doi: 10.1016/j.athoracsur.2009.09.026.

PMID:
20103217
8.

Pericardial effusion in patients with cancer: outcome with contemporary management strategies.

Laham RJ, Cohen DJ, Kuntz RE, Baim DS, Lorell BH, Simons M.

Heart. 1996 Jan;75(1):67-71.

9.

Predictors of mortality in connective tissue disease-associated pulmonary arterial hypertension: a cohort study.

Ngian GS, Stevens W, Prior D, Gabbay E, Roddy J, Tran A, Minson R, Hill C, Chow K, Sahhar J, Proudman S, Nikpour M.

Arthritis Res Ther. 2012 Oct 5;14(5):R213. doi: 10.1186/ar4051.

10.

Predicting survival in pulmonary arterial hypertension: insights from the Registry to Evaluate Early and Long-Term Pulmonary Arterial Hypertension Disease Management (REVEAL).

Benza RL, Miller DP, Gomberg-Maitland M, Frantz RP, Foreman AJ, Coffey CS, Frost A, Barst RJ, Badesch DB, Elliott CG, Liou TG, McGoon MD.

Circulation. 2010 Jul 13;122(2):164-72. doi: 10.1161/CIRCULATIONAHA.109.898122. Epub 2010 Jun 28.

11.

Risk factors affecting the survival of patients with pericardial effusion submitted to subxiphoid pericardiostomy.

Dosios T, Theakos N, Angouras D, Asimacopoulos P.

Chest. 2003 Jul;124(1):242-6.

PMID:
12853529
12.

Frequency and prognostic significance of pericardial effusion in primary pulmonary hypertension. PPH Study Group. Primary pulmonary hypertension.

Hinderliter AL, Willis PW 4th, Long W, Clarke WR, Ralph D, Caldwell EJ, Williams W, Ettinger NA, Hill NS, Summer WR, de Biosblanc B, Koch G, Li S, Clayton LM, Jöbsis MM, Crow JW.

Am J Cardiol. 1999 Aug 15;84(4):481-4, A10.

PMID:
10468096
13.

Prognostic Value of Pericardial Effusion on Serial Echocardiograms in Pulmonary Arterial Hypertension.

Batal O, Dardari Z, Costabile C, Gorcsan J, Arena VC, Mathier MA.

Echocardiography. 2015 Feb 13. doi: 10.1111/echo.12909. [Epub ahead of print]

PMID:
25682779
14.

Survival of Chinese patients with pulmonary arterial hypertension in the modern treatment era.

Zhang R, Dai LZ, Xie WP, Yu ZX, Wu BX, Pan L, Yuan P, Jiang X, He J, Humbert M, Jing ZC.

Chest. 2011 Aug;140(2):301-9. doi: 10.1378/chest.10-2327. Epub 2011 Feb 17.

PMID:
21330386
15.

Clinical outcome of small cell lung cancer with pericardial effusion but without distant metastasis.

Niho S, Kubota K, Yoh K, Goto K, Ohmatsu H, Nihei K, Ohe Y, Nishiwaki Y.

J Thorac Oncol. 2011 Apr;6(4):796-800. doi: 10.1097/JTO.0b013e318208ec77.

PMID:
21258253
16.

Subxiphoid pericardial window for pericardial effusion in end-stage renal disease.

Figueroa W, Alankar S, Pai N, Dave M.

Am J Kidney Dis. 1996 May;27(5):664-7.

PMID:
8629625
17.

Pericardial abnormalities predict the presence of echocardiographically defined pulmonary arterial hypertension in systemic sclerosis-related interstitial lung disease.

Fischer A, Misumi S, Curran-Everett D, Meehan RT, Ulrich SK, Swigris JJ, Frankel SK, Cosgrove GP, Lynch DA, Brown KK.

Chest. 2007 Apr;131(4):988-92.

PMID:
17426200
18.

Outcomes of primary and secondary treatment of pericardial effusion in patients with malignancy.

Tsang TS, Seward JB, Barnes ME, Bailey KR, Sinak LJ, Urban LH, Hayes SN.

Mayo Clin Proc. 2000 Mar;75(3):248-53.

PMID:
10725950
19.
20.

Cardiac tamponade caused by primary lung cancer and the management of pericardial effusion.

Okamoto H, Shinkai T, Yamakido M, Saijo N.

Cancer. 1993 Jan 1;71(1):93-8.

PMID:
8416732
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk